Mindpeak Welcomes Christiaan Neeleman to the Board of Directors

The role of AI in pathology isn’t just evolving – it’s accelerating. It’s helping pathologists turn complex data into faster, more consistent answers for patients. At Mindpeak, we’re proud to be part of that change. Today, we’re taking another big step forward through a new collaboration with PathGroup – one of the leading providers of anatomic, clinical, molecular and digital pathology services in the U.S.

This partnership goes beyond collaboration; it marks a powerful step toward bringing AI into everyday diagnostics. By combining Mindpeak’s proprietary image analysis technology with PathGroup’s extensive, pathologist-led network, we’re laying the groundwork for a new era of precision and efficiency in pathology.

Together, we’ll support pathologists integrate AI seamlessly into their workflows – enhancing speed, consistency and equity in diagnostics. The result: faster, more reliable insights for patients and more time for pathologists to focus on what matters most – patient care.

At Mindpeak, we believe the future of pathology is AI-augmented, not AI-replaced. Through partnerships like this, that future is becoming reality – one slide at a time.

‍

‍

Read more here

We’re proud to introduce PhenoScout AI, our next-generation multiplex immunofluorescence (mIF) analysis solution.

By automating phenotype identification, biomarker quantification, and spatial readouts, PhenoScout AI reduces variability and supports large-scale studies. The solution is designed for pharma, diagnostics, and academic research to accelerate translational medicine.

👉 Learn more

‍

At Mindpeak, our vision is clear: world-class AI diagnostics should be available to every pathology lab, everywhere. By partnering with leading technology providers, we’re removing barriers to adoption and making AI-powered precision diagnostics a practical reality for labs worldwide.

Seamless AI Integration with Pathomation

Through our strategic collaboration with Pathomation, a globally trusted provider of digital pathology platforms, Mindpeak’s CE-IVD certified AI algorithms – including Ki-67, HER2, and zero-click PD-L1 scoring across multiple tissue types – are now natively integrated into Pathomation’s solutions.

This partnership means laboratories can:

• Adopt advanced AI instantly – No extra development, integrations, or technical overhead required.
• Work within existing workflows – Our algorithms run directly inside Pathomation’s widely adopted platform.
• Deliver faster, more consistent results – Helping pathologists make confident, high-quality diagnostic decisions for patients everywhere.
  
  

Reaching More Labs, Globally

Pathomation’s worldwide presence, with distributor networks and users spanning Europe, Asia, and Latin America, ensures that AI-powered image analysis is accessible to more labs and more patients across the globe. Together, we’re removing geographic and technical barriers to bring state-of-the-art diagnostics to every corner of the world.

“Every partnership we form moves us closer to our goal: AI-powered image analysis in every lab, for every patient. Our collaboration with Pathomation is an important step toward making this vision a reality.” – Felix Faber, CEO, Mindpeak

‍

🔗 Learn more about the partnership and read the full press release: https://tissuepathology.com/2025/08/21/pathomation-and-mindpeak-forge-strategic-partnership-to-accelerate-ai-adoption-in-digital-pathology-workflows/

‍

‍